NLRP3 and Mental deterioration: Preoperative administration of TUDCA downregulated the expression of GRP78 and XBP1 and inhibited NLRP3 inflammasome activation and neuroinflammation, thereby exhibiting an obvious therapeutic effect against postoperative cognitive decline.